STAGE-I PRIMARY MELANOMA - CONTROVERSIAL ISSUES

被引:0
|
作者
CAVEGN, B [1 ]
PUPPIN, D [1 ]
BURG, G [1 ]
机构
[1] ESCOLA MED SANTA CASA MISERICORDIA, VITORIA ES, BRAZIL
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Melanoma is still the most frequent cause of death for diseases arising in the skin. The mortality rate is approximately 25%, tumor thickness, sex and localization being the most important prognostic factors. It is still unclear whether the margin of excision, type of anaesthesia and the pattern of follow-up should be taken into consideration in relation to the individual prognostic groups.
引用
收藏
页码:1883 / 1888
页数:6
相关论文
共 50 条
  • [41] PROGNOSTIC-SIGNIFICANCE OF DNA ANEUPLOIDY IN STAGE-I CUTANEOUS MELANOMA
    KHEIR, SM
    BINES, SD
    VONROENN, JH
    SOONG, SJ
    URIST, MM
    COON, JS
    ANNALS OF SURGERY, 1988, 207 (04) : 45 - 461
  • [42] EFFECT OF ANATOMICAL LOCATION ON PROGNOSIS IN PATIENTS WITH CLINICAL STAGE-I MELANOMA
    ROGERS, GS
    KOPF, AW
    RIGEL, DS
    FRIEDMAN, RJ
    LEVINE, JL
    LEVENSTEIN, M
    BART, RS
    MINTZIS, MM
    ARCHIVES OF DERMATOLOGY, 1983, 119 (08) : 644 - 649
  • [43] DESMOPLASIA AND NEUROTROPISM AS PROGNOSTIC VARIABLES IN SURVIVAL OUTCOME FOR STAGE-I MELANOMA
    BAER, S
    RAYMOND, AK
    SCHULTZ, D
    SYNNESTVEDT, M
    ELDER, DE
    LABORATORY INVESTIGATION, 1994, 70 (01) : A44 - A44
  • [44] DERMATOLOGICAL APPROACHES TO STAGE-I MELANOMA - NATIONAL INQUIRY IN DERMATOLOGICAL PRACTICES
    POISSONSALOMON, AS
    MLIKACABANNE, N
    COSQUER, M
    DURIEUX, P
    SAIAG, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1995, 122 (05): : 259 - 262
  • [45] IS DNA PLOIDY OF PROGNOSTIC-SIGNIFICANCE IN STAGE-I CUTANEOUS MELANOMA
    GATTUSO, P
    REDDY, V
    SOLANS, E
    KATHURIA, S
    ARANHA, GV
    JACOBS, HK
    WALLOCH, J
    SURGERY, 1990, 108 (04) : 702 - 709
  • [46] EVALUATION OF PROGNOSTIC CHARACTERISTICS OF STAGE-I CUTANEOUS MALIGNANT-MELANOMA
    TAN, GJKH
    BAAK, JPA
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1984, 6 (03): : 147 - 154
  • [47] A CONTROLLED TRIAL OF ADJUVANT IMMUNOTHERAPY IN STAGE-I MALIGNANT-MELANOMA
    ABDI, EA
    PATERSON, AHG
    HARBORA, D
    WILLANS, D
    JERRY, LM
    MCPHERSON, TA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (03): : 155 - 156
  • [48] PROGNOSTIC VALUE OF LEUKOCYTE ADHERENCE INHIBITION REACTIVITY IN STAGE-I MELANOMA
    WILSON, BJ
    PALMQUIST, M
    FLETCHER, WS
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 992 - 992
  • [49] STAGE-I MELANOMA OF THE SKIN - EVALUATION OF PROGNOSIS ACCORDING TO HISTOLOGIC CHARACTERISTICS
    VANDERESCH, EP
    CASCINELLI, N
    PREDA, F
    MORABITO, A
    BUFALINO, R
    CANCER, 1981, 48 (07) : 1668 - 1673
  • [50] HAZARD-RATE ANALYSIS IN STAGE-I MALIGNANT-MELANOMA
    ROGERS, GS
    KOPF, AW
    RIGEL, DS
    FRIEDMAN, RJ
    LEVENSTEIN, M
    BART, RS
    ARCHIVES OF DERMATOLOGY, 1986, 122 (09) : 999 - 1002